Author

Raymond Huang

Observed name: Raymond H Huang

Observed institutions: Brigham and Women's Hospital, Harvard University, University of San Diego, Center for Neuro-Oncology, Sarcoma Oncology Center, Dana-Farber Brigham Cancer Center

OpenAlex ID: A5110690978

Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas

2020 · Jerrold L Boxerman, Chad C Quarles, et al. · Neuro-Oncology · 208

Conformation and protein interactions of intramolecular DNA and phosphorothioate four-way junctions

2020 · Maria Troisi, Mitchell Klein, et al. · Experimental Biology and Medicine · 6

NIMG-56IMMUNOTHERAPY RESPONSE ASSESSMENT IN NEURO-ONCOLOGY (iRANO): A REPORT OF THE RANO WORKING GROUP

2015 · Hideho Okada, Michael Weller, et al. · Neuro-Oncology · 5

Nimg-43. Longitudinal Tracking and Growth Rate Characterization of Brain Metastases on Magnetic Resonance Imaging

2019 · Jay Patel, Andrew Beers, et al. · Neuro-Oncology · 1

Phase I study to evaluate the safety and efficacy of rivoceranib (apatinib) and nivolumab in patients with unresectable or metastatic cancer.

2019 · Sant P. Chawla, Victoria S. Chua, et al. · Journal of Clinical Oncology · 1

Path-08. the Ivy Glioblastoma Patient Atlas - a Novel Clinical and Radio-genomics Resource for Early Phase Clinical Trial Design and Interpretation

2018 · Keith Ligon, Janine Lupo, et al. · Neuro-Oncology · 1

Prediction of Survival During Immunotherapy of Recurrent High-Grade Glioma Using End-to-End CNN Deep Learning Versus Radiomics Models

2025 · Geoffrey Young, Qi Wan, et al. · Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition

Dddr-24. Real World Experience Using the Idh Inhibitor Ivosidenib in Idh Mutant Glioma: Tolerability and Outcomes

2024 · Tyler Lanman, Gilbert Youssef, et al. · Neuro-Oncology

Biom-47. Predictors of Seizure at Onset Using a Functional Variant Analysis of Targeted Next Generation Sequencing in Gbm

2022 · Mary Jane Lim-Fat, Rifaquat Rahman, et al. · Neuro-Oncology

Dres-08. Clinical Significance of Hypermutation in Gliomas

2019 · Mehdi Touat, Yvonne Li, et al. · Neuro-Oncology

Evaluation of the nuclease resistance of DNA four‐way junctions.

2018 · Gaston Moorhead, Raymond Huang, et al. · The FASEB Journal

Characterization of the secondary structure and protein binding affinity of an intramolecular DNA four‐way junction.

2018 · Andrew Smith, Yonatan Kebede, et al. · The FASEB Journal

Nimg-80. Shape Attributes of Enhancing Lesion Boundaries Can Differentiate Tumor Recurrence From Pseudo-progression on Routine Brain Mri Scans: Preliminary Findings

2017 · Marwa Isamail, Prateek Prasanna, et al. · Neuro-Oncology

Rare-15. Prognostic Factors, Treatment and Outcome in Patients With Intracranial Hemangioblastoma: a Study of 3449 Patients From the National Cancer Data Base

2017 · Harrison Bai, Yuqian Huang, et al. · Neuro-Oncology

Works count: 14

Citation count: 222

H-index: 3

I10-index: 1